Birmingham Biotech

NoriZite™ Nasal Spray blocks infection with Omicron SARS-CoV-2 variant in cell culture

Birmingham, UK, 15th December 2022 / Sciad Newswire / Birmingham Biotech LTD, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, today announces new evidence from the University of Birmingham that shows NoriZite™ Nasal Spray can block the infection of the Omicron variant of SARS-CoV-2 in lab-based tests. These promising new laboratory...

New NoriZite™ Nasal Spray launches in the UK

Birmingham, UK,  28th October 2022 / Sciad Newswire / Birmingham Biotech LTD, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, today announces that NoriZite™ Nasal Spray, an easy-to-use nasal device designed to block and trap inhaled virus particles, is now available to buy in the UK.

New BHM Anti-Viral Nasal Spray Launches in Singapore

Birmingham, UK, 28th April 2022 / Sciad Newswire / Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, today announces the Singapore launch of its latest technology, BHM Anti-Viral Nasal Spray, an easy-to-use nasal device with a unique patented formulation, Norizite™, designed to help prevent infection from the inhalation...
29-31 Castle Street High Wycombe, HP13 6RU